で公開中です! 詳しく見る
BIBのアイコン

ProShares Ultra NASDAQ Biotechnology

105.10 USD
-6.01
5.41%
終値時点 更新済み 10月16日 16:00 EDT
1日
-5.41%
5日間
-4.99%
1か月
-3.57%
3か月
5.35%
6か月
21.19%
年初来
31.97%
1年
58.74%
5年間
21.08%
10年間
157.53%

ニュース

ポジティブ
ニュートラル
ネガティブ
センチメント 3か月間
ポジティブ 0%
ニュートラル 0%
ネガティブ 0%
ニュートラル
Seeking Alpha
5 か月前
Medical Technology Stocks: Innovation Endures As Valuations Reset
Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.
Medical Technology Stocks: Innovation Endures As Valuations Reset
ポジティブ
Seeking Alpha
11 か月前
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.
Investing In Health Stocks - How Policy Clarity Is Opening Doors
ポジティブ
Seeking Alpha
11 か月前
BIB: A Tactical 2 X Leveraged Biotech ETF
BIB seeks 2× the daily return of the Nasdaq Biotechnology Index, amplifying both gains and losses through leverage. A higher expense ratio reflects leverage costs and management fees; 24 bps difference largely from borrowing and rebate adjustments. Designed for tactical investors, contrasting with MPT's long-term strategic approach assuming market efficiency.
BIB: A Tactical 2 X Leveraged Biotech ETF
ネガティブ
Investors Business Daily
昨年
Pharma Tariffs Back In Spotlight On New Trump Threat
President Donald Trump delivered the pharmaceutical industry another blow this week, threatening 100% tariffs on some companies.
Pharma Tariffs Back In Spotlight On New Trump Threat
ニュートラル
Investors Business Daily
昨年
Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn
Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month, making good on months of threats.
Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn
ネガティブ
Investors Business Daily
昨年
Trump Threatens To Slam Pharmaceuticals With Up To 200% Tariffs
President Donald Trump threatened Tuesday to levy up to 200% tariffs on drugs imported into the U.S. "very soon."
Trump Threatens To Slam Pharmaceuticals With Up To 200% Tariffs
ニュートラル
Seeking Alpha
昨年
Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Healthcare Sector Checkup As U.S. Looks To Change Regulations
ニュートラル
Seeking Alpha
昨年
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Seeking Stocks With Vitality In The Volatile Healthcare Sector
ニュートラル
Seeking Alpha
2 年前
Will The Next Batch Of Tech Earnings Encourage Investors To Rotate Back In?
All eyes will remain on big tech this week with Microsoft, Amazon, Meta, and Apple set to report for Q2. Outlier earnings this week include - McDonald's & Boeing. During this second peak week of the Q2 season, nearly 2,500 companies are set to report.
Will The Next Batch Of Tech Earnings Encourage Investors To Rotate Back In?
ポジティブ
InvestorPlace
2 年前
Wall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
Some of the market's favorite biotech stocks have created immense wealth, as in the recent weight-loss drug stock boom.  On May 26, Viking Therapeutics (NASDAQ: VKTX ) was trading around $20.25.
価格チャートは Lightweight Charts™ を使用して実装されています